Huynh C, Dingemanse J, Zu Schwabedissen H, Fonseca M, Sidharta P
Clin Transl Sci. 2024; 17(7):e13883.
PMID: 39010703
PMC: 11249824.
DOI: 10.1111/cts.13883.
Henkel L, Jehn U, Tholking G, Reuter S
Front Transplant. 2024; 2:1160752.
PMID: 38993881
PMC: 11235362.
DOI: 10.3389/frtra.2023.1160752.
Sandritter T, Chevalier R, Abt R, Shakhnovich V
Pharmaceuticals (Basel). 2023; 16(6).
PMID: 37375836
PMC: 10302140.
DOI: 10.3390/ph16060889.
DAngelo D, Quarta E, Glieca S, Varacca G, Flammini L, Bertoni S
Pharmaceutics. 2023; 15(3).
PMID: 36986883
PMC: 10055879.
DOI: 10.3390/pharmaceutics15031023.
Wheeler A, Eberhard C, Mosher E, Yuan Y, Wilkins H, Seneviratne H
Drug Metab Dispos. 2023; 51(3):350-359.
PMID: 36627162
PMC: 10029823.
DOI: 10.1124/dmd.122.001043.
Establishment and Characterization of Novel Human Intestinal In Vitro Models for Absorption and First-Pass Metabolism Studies.
Przybylla R, Mullins C, Krohn M, Oswald S, Linnebacher M
Int J Mol Sci. 2022; 23(17).
PMID: 36077251
PMC: 9456142.
DOI: 10.3390/ijms23179861.
Oral drug delivery for immunoengineering.
Le T, Aguilar B, Mangal J, Acharya A
Bioeng Transl Med. 2022; 7(1):e10243.
PMID: 35111945
PMC: 8780903.
DOI: 10.1002/btm2.10243.
Vitamin D levels do not cause vitamin-drug interactions with dexamethasone or dasatinib in mice.
Annu K, Yasuda K, Caufield W, Freeman 3rd B, Schuetz E
PLoS One. 2021; 16(10):e0258579.
PMID: 34669728
PMC: 8528301.
DOI: 10.1371/journal.pone.0258579.
Next-Generation Intestinal Toxicity Model of Human Embryonic Stem Cell-Derived Enterocyte-Like Cells.
Ryu B, Son M, Jung K, Kim U, Kim J, Kwon O
Front Vet Sci. 2021; 8:587659.
PMID: 34604364
PMC: 8481684.
DOI: 10.3389/fvets.2021.587659.
Gutsy science: In vitro systems of the human intestine to model oral drug disposition.
Arian C, Imaoka T, Yang J, Kelly E, Thummel K
Pharmacol Ther. 2021; 230:107962.
PMID: 34478775
PMC: 8821120.
DOI: 10.1016/j.pharmthera.2021.107962.
Effect of the Most Relevant CYP3A4 and CYP3A5 Polymorphisms on the Pharmacokinetic Parameters of 10 CYP3A Substrates.
Saiz-Rodriguez M, Almenara S, Navares-Gomez M, Ochoa D, Roman M, Zubiaur P
Biomedicines. 2020; 8(4).
PMID: 32331352
PMC: 7235792.
DOI: 10.3390/biomedicines8040094.
Hepatic and intestinal biotransformation gene expression and drug disposition in a dextran sulfate sodium-induced colitis mouse model.
Fan X, Ding X, Zhang Q
Acta Pharm Sin B. 2020; 10(1):123-135.
PMID: 31993311
PMC: 6976992.
DOI: 10.1016/j.apsb.2019.12.002.
Interaction of cyclosporine with phenobarbital in cats: a preliminary study.
Hoshino Y, Inden T, Otaka R, Fukui D, Satoh H, Katayama M
J Vet Med Sci. 2019; 81(11):1621-1623.
PMID: 31597813
PMC: 6895620.
DOI: 10.1292/jvms.19-0339.
Immunomodulatory effects of tacrolimus (FK506) for the treatment of allergic diseases.
Kandikattu H, Mishra A
Int J Cell Biol Physiol. 2019; 1(1-2):5-13.
PMID: 31595270
PMC: 6783126.
DOI: 10.5281/zenodo.2530969.
Pharmacokinetics in children with chronic kidney disease.
Schijvens A, de Wildt S, Schreuder M
Pediatr Nephrol. 2019; 35(7):1153-1172.
PMID: 31375913
PMC: 7248054.
DOI: 10.1007/s00467-019-04304-9.
Non-invasive delivery strategies for biologics.
Anselmo A, Gokarn Y, Mitragotri S
Nat Rev Drug Discov. 2018; 18(1):19-40.
PMID: 30498202
DOI: 10.1038/nrd.2018.183.
A Novel In vitro Experimental System for the Evaluation of Enteric Drug Metabolism: Cofactor-Supplemented Permeabilized Cryopreserved Human Enterocytes (MetMax™ Cryopreserved Human Enterocytes).
Li A, Amaral K, Ho M
Drug Metab Lett. 2018; 12(2):132-137.
PMID: 30124163
PMC: 6350199.
DOI: 10.2174/1872312812666180820142141.
Kinetics of carnitine concentration after switching from oral administration to intravenous injection in hemodialysis patients.
Suzuki A, Sakai Y, Hashimoto K, Osawa H, Tsuruoka S
Ren Fail. 2018; 40(1):196-200.
PMID: 29616582
PMC: 6014372.
DOI: 10.1080/0886022X.2018.1455587.
Pharmacokinetics, Tissue Distribution, and Elimination of Three Active Alkaloids in Rats after Oral Administration of the Effective Fraction of Alkaloids from Ramulus Mori, an Innovative Hypoglycemic Agent.
Yang S, Mi J, Liu Z, Wang B, Xia X, Wang R
Molecules. 2017; 22(10).
PMID: 28954438
PMC: 6151740.
DOI: 10.3390/molecules22101616.
Diltiazem co treatment with cyclosporine for induction of disease remission in sight-threatening non-infectious intraocular inflammation.
Shalaby U
Jpn J Ophthalmol. 2016; 61(2):169-178.
PMID: 27943089
DOI: 10.1007/s10384-016-0490-9.